Evra Transdermal Contraceptive System is a modern method of hormonal contraception in the form of a transdermal patch. The product prevents unintended pregnancy through a continuous and uniform micro-dosage of hormonal components absorbed directly through the skin, eliminating the reliance on a strict hourly pill schedule.

Indications: Evra is used for:

• Reliable prevention of unintended pregnancy

• Continuous maintenance of the contraceptive effect throughout the entire week

• Easing premenstrual discomfort and regulating the menstrual cycle

• Safe contraception without gastrointestinal contact or irritation

Reasons for Use:

• Seeking an alternative method of contraception in case of oral pill intolerance

• The desire to simplify the protection scheme to a single weekly action

• The need to eliminate the “forgotten pill” factor and its associated anxiety

• An active lifestyle requiring a discreet, water-resistant, and resilient contraceptive

Key Features:

• Features a synergistic combination of norelgestromin and ethinyl estradiol

• Inhibits ovulation and increases cervical mucus viscosity to block sperm passage

• Demonstrates maximum contraceptive efficacy (Pearl Index close to zero)

• Adheres firmly to the body, retaining its properties during bathing, sauna visits, and athletic activities

• The 9-patch pack provides a complete 3-month (90-day) course of contraceptive protection

Dosage Form: Evra — transdermal patch, 9 patches per box (3 sealed foil pouches containing 3 patches each)

Manufacturer: Janssen Pharmaceutica / Johnson & Johnson (Belgium / Germany)

Active Ingredients:

• Norelgestromin — 6.00 mg

• Ethinyl estradiol — 0.60 mg (with a continuous release rate of 203 mcg/day and 33.9 mcg/day, respectively)

#Evra #EvraPatch #ContraceptivePatch #BirthControl #HormonalContraception #PregnancyProtection #Norelgestromin #EthinylEstradiol #Janssen #MedsInIsrael #PharmacyDelivery #Evra9pcs